Prior exposure to a behaviorally sensitizing regimen of d-methamphetamine does not alter the striatal dopaminergic neurotoxic regimen

Addiction Biology

Volumn 5, Issue 3, 2000, Pages 361-367

  Miller, Diane B ^a   O'Callaghan, James P ^a   Johnson, E Anne ^a  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; METHAMPHETAMINE; PSYCHOSTIMULANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC ACTIVITY; DRUG DEPENDENCE; FEMALE; LOCOMOTION; MOUSE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

EID: 0033910550     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2000.tb00203.x     Document Type: Conference Paper

References (24)

1. 1. Berridge KG, Robinson TE. The mind of an addicted brain: neural sensitization of wanting versus liking. Curr Direct Psychol Sci 1994;4: 71-6.
2. 2. Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res 1996;738:172-5.
3. 3. O'Callaghan MP, Miller DB, Pennypacker KR. Chronic dopaminergic signalling in the basal ganglia: a damage perspective on kinases and Fos-related antigens. Addict Biol 2000;5:369-77.
4. 4. Sonsalla PK, Riordan DE, Heikkila RE. Competitive and noncompetitive antagonists at the N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther 1991;256: 506-12.
5. 5. White FJ, Wolf ME. Psychomotor stimulants. In: Pratt J, editor. The biological bases of drug tolerance and dependence. New York: Academic Press; 1991, pp. 153-97.
6. 6. Fienberg AA, Hiroi N, Mermelstein PG et al. 1998. DARPP-32: regulator of the efficacy of dopaminergic neurotransmission. Science 281:838-42.
7. 7. Segal DS. Behavioral and neurochemical correlates of repeated d-amphetamine administration. Adv Biochem Psychopharmacol 1975;13:247-62.
8. 8. Robinson T, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 1986;11:157-98.
9. 9. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 1997;278:58-70.
10. 10. Lieberman J, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997;17:205-29.
11. 11. Bowyer JF, Davies DL, Schmued L et al. Further studies of the role of hyperthermia in methamphetamine neurotoxicity. J Pharmacol Exp Ther 1994;268:1571-80.
12. 12. Miller DB, O'Callaghan JP. Neurotoxicity of d-amphetamine in the C57BL/6J and CD-1 mouse. Ann NY Acad Sci 1996;801:148-67.
13. 13. O'Callaghan JP, Miller DB. Quantification of reactive gliosis as an approach to neurotoxicity assessment. In: Assessing neurotoxicity of drugs of abuse. Erinoff L, editor. National Institute on Drug Abuse Monograph 136. Washington DC: US Government Printing Office; 1993, pp. 188-312.
14. 14. O'Callaghan JP, Miller DB. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994;270:741-51.
15. 15. Phillips TJ, Dickinson S, Burkhart-Kasch S. Behavioral sensitization to drug stimulant effects in C57BL/6J and DBA/2J inbred mice. Behav Neurosci 1994;108:789-803.
16. 16. Miller DB, O'Callaghan JP. Environment-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse. J Pharmacol Exp Ther 1994;270:752-60.
17. 17. O'Callaghan, J. P. Quantification of a glial fibrillary acidic protein: comparison of slot-immunobinding assays with a novel sandwich ELISA. Neurotoxicol Teratol 1991;13:275-81.
18. 18. Smith PK, Kronh RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76-85.
19. 19. Kuribara H. Inhibitory effect of restraint on induction of behavioral sensitization to methamphetamine and cocaine in mice. Pharmacol Biochem Behav 1996;54:327-31.
20. 20. Nestler EJ, Hope BT, Widnell KL. Drug addiction: a model for the molecular basis of neuronal plasticity. Neuron 1993;11:995-1006.
21. 21. Wang XB, Funada M, Imai Y et al. rGbetal: a psychostimulant-regulated gene essential for establishing cocaine sensitization. J Neurosci 1997;17: 5993-6000.
22. 22. Hiroi N, Brown JR, Haile CN, Ye H., Greenber, HE, Nestle, EJ. Fos B mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci USA 1997;94:10397-402.
23. 23. Kolta MG, Shreve P, DeSouza V, Uretsky NJ. Time-course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine. Neuropharmacology 1985;24:823-9.
24. 24. Philips SR, Robson AM. Amphetamine-stimulated release of endogenous dopamine from the rat caudate nucleus in vivo. Neurochem Res 1983;8:731-41.